Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03362164

Evaluation of HEArt invoLvement in Patients With FABRY Disease

Prospective Monocentric Cohort Study to Evaluate Predictors for Heart Failure and Sudden Cardiac Death in Patients With Fabry Disease

Status
Recruiting
Phase
Study type
Observational
Enrollment
650 (estimated)
Sponsor
Wuerzburg University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

This study evaluates predictors for the incidence of arrhythmias and sudden cardiac death as well as terminal heart failure in patients with Fabry disease.

Detailed description

Fabry disease is a rare disease and part of the group of lysosomal storage disorders. Natural history of Fabry disease has proven poor survival to ages \>50 years outlining the importance to evaluate cardiac symptoms and outcomes of patients with Fabry disease. This study is a prospective cohort study and observes patients since 2001. Through this long-term experience and the relative high number of patients this study is suggested to help estimating the risk of cardiac arrhythmias and sudden cardiac death (SCD) as well as death or heart transplantation due to terminal heart failure. All patients in treatment in the Fabry Center Wuerzburg (FAZiT) are included in this study if informed consent is provided.

Conditions

Timeline

Start date
2001-01-01
Primary completion
2032-03-01
Completion
2032-03-01
First posted
2017-12-05
Last updated
2022-07-07

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03362164. Inclusion in this directory is not an endorsement.